Analysis of data from a randomized trial finds trabeculectomy typically is the better financial bet than tube shunt surgery as a first option to treat glaucoma.

The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a ...

In this podcast, Philadelphia cornea and glaucoma surgeon Brian Shafer, MD, discusses the procedures and processes involved ...

About Sight Sciences Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ ...

We’re used to technology getting smaller. The chips that power smartphones in our pockets are now so tiny they can only be seen under a microscope. That same trend is reshaping modern eye care. Over ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and sponsoring an awareness campaign in one of its priority therapeutic areas.

Please provide your email address to receive an email when new articles are posted on . Ptosis and strabismus occurred in 3.7% and 1.7% of patients, respectively, and 1% had both. Most patients in all ...

Sight Sciences (Nasdaq:SGHT) today announced new clinical data supporting its Omni minimally invasive glaucoma surgery (MIGS) device. Menlo Park, California–based Sight Sciences conducted a systematic ...

Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...